NYSE:VAPOVapotherm Stock Price, Forecast & News

Vapotherm's stock was trading at $7.79 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, VAPO shares have increased by 241.8% and is now trading at $26.63. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vapotherm in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Vapotherm.

Vapotherm is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Vapotherm.

Vapotherm Inc (NYSE:VAPO) released its quarterly earnings data on Tuesday, May, 5th. The company reported ($0.66) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.56) by $0.10. The business earned $19.12 million during the quarter, compared to the consensus estimate of $18.90 million. Vapotherm had a negative return on equity of 109.58% and a negative net margin of 94.57%. View Vapotherm's earnings history.

Vapotherm issued an update on its first quarter 2020 Pre-Market earnings guidance on Monday, April, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $18.9-18.9 million, compared to the consensus revenue estimate of $13.61 million.

3 analysts have issued 1-year price objectives for Vapotherm's stock. Their forecasts range from $30.00 to $32.00. On average, they anticipate Vapotherm's stock price to reach $31.00 in the next year. This suggests a possible upside of 16.4% from the stock's current price. View analysts' price targets for Vapotherm.

Media headlines about VAPO stock have been trending somewhat positive on Saturday, InfoTrie reports. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Vapotherm earned a news sentiment score of 2.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutVapotherm.

Some companies that are related to Vapotherm include Inovio Pharmaceuticals (INO), AtriCure (ATRC), Cantel Medical (CMD), Glaukos (GKOS), Luminex (LMNX), Shockwave Medical (SWAV), Cardiovascular Systems (CSII), Silk Road Medical (SILK), Axonics Modulation Technologies (AXNX), Atrion (ATRI), Cerus (CERS), Tactile Systems Technology (TCMD), Cryolife (CRY), OraSure Technologies (OSUR) and Orthopediatrics (KIDS). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Vapotherm investors own include NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Walt Disney (DIS), Inovio Pharmaceuticals (INO), Pfizer (PFE), Square (SQ), Aphria (APHA), Digi International (DGII) and Gilead Sciences (GILD).

(VAPO) raised $60 million in an IPO on Wednesday, November 14th 2018. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Vapotherm trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAPO."

Vapotherm's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Perceptive Advisors LLC (7.84%), BlackRock Inc. (4.73%), Wells Fargo & Company MN (2.65%), Driehaus Capital Management LLC (2.22%), ThornTree Capital Partners LP (2.11%) and State Street Corp (1.20%). Company insiders that own Vapotherm stock include Anthony L Arnerich, Elizabeth H Weatherman, Healthcare Holding BV Gilde, James W Liken, John Landry, Joseph Army and Michael Mcqueen. View institutional ownership trends for Vapotherm.

VAPO stock was sold by a variety of institutional investors in the last quarter, including Redmile Group LLC, Taylor Frigon Capital Management LLC, Perceptive Advisors LLC, Taylor Frigon Capital Management LLC, Morgan Stanley, UBS Group AG, BlackRock Inc., and Deutsche Bank AG. View insider buying and selling activity for Vapotherm.

VAPO stock was bought by a variety of institutional investors in the last quarter, including ThornTree Capital Partners LP, JPMorgan Chase & Co., Wells Fargo & Company MN, Aperimus Capital LLC, Driehaus Capital Management LLC, GSA Capital Partners LLP, State Street Corp, and Invesco Ltd.. Company insiders that have bought Vapotherm stock in the last two years include Anthony L Arnerich, Elizabeth H Weatherman, Healthcare Holding BV Gilde, James W Liken, John Landry, Joseph Army, and Michael Mcqueen. View insider buying and selling activity for Vapotherm.

Shares of VAPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of VAPO stock can currently be purchased for approximately $26.63.

Vapotherm has a market capitalization of $567.22 million and generates $48.10 million in revenue each year. The company earns $-51,060,000.00 in net income (profit) each year or ($2.74) on an earnings per share basis. Vapotherm employs 276 workers across the globe.

The official website for Vapotherm is www.vapotherm.com.

Vapotherm's mailing address is 100 DOMAIN DRIVE, EXETER NH, 03833. The company can be reached via phone at 603-658-0411 or via email at [email protected]